Health Care

Aetna launches new doctor incentive program

A major health insurer is giving New Jersey doctors more money to provide a holistic approach to care. Aetna has launched a new Patient-Centered Medical Home program aimed at rewarding doctors who meet guidelines designed to improve patient health and reduce hospitalizations. The program is being rolled out first in New Jersey and Connecticut, but ...

Read More »

Watson again taps EDA for global RD center in North Brunswick

Citing a positive experience when relocating its headquarters to Parsippany, Watson Pharmaceuticals Inc. announced Monday the company will open a new global research and development center in North Brunswick with the help of the Economic Development Authority. The company signed a 32,000-square-foot lease in the EDA’s Technology Centre of New Jersey, and will immediately begin ...

Read More »

Hackensack UMC latest to apply for ACO

Hackensack University Medical Center became the latest New Jersey care provider to apply for an accountable-care organization with the Centers for Medicare and Medicaid Services today. HUMC applied for the creation of the ACO with 122 physicians, centered around five physician offices. If accepted, the ACO would begin operations on April 1. “At Hackensack UMC, ...

Read More »

For biotech CEO, N.J. location is a must to lead turnaround

A few months after leaving his home state of New Jersey to become CEO of a small Texas biotech firm, Paul Thomas sat down with LifeCell Inc.‘s board of directors to have a frank talk. The company’s regenerative medicine technology was everything Thomas had hoped for, but to reach the technology’s commercial potential, he would ...

Read More »

Packing his bags

While in talks with Chris Christie about becoming the governor-elect’s chief of staff two years ago, Richard Bagger downloaded a job description from the website of the National Governors Association. The document lists the many hats a chief of staff must wear — including chief strategist, crisis coordinator and headhunter. At the end is a ...

Read More »

Celgene purchases Mass. biotech in 350M cash deal

Summit-based biotech firm Celgene Corp. announced today it will buy privately held biotechnology company Avila Therapeutics Inc., of Bedford, Mass., for $350 million in cash, plus up to $575 million more in milestone payments. Avila’s research and development platforms will complement Celgene’s work in hematology and immune inflammatory diseases, which is a growing area at ...

Read More »